Format

Send to

Choose Destination
Clin Gastroenterol Hepatol. 2006 Nov;4(11):1309-13.

Surveillance of dysplasia in inflammatory bowel disease: The gastroenterologist-pathologist partnership.

Author information

1
Department of Medicine, University of Chicago, Chicago, Illinois, USA. drubin@uchicago.edu

Abstract

Cancer prevention in inflammatory bowel disease depends on the detection of precancerous dysplasia during scheduled screening and surveillance colonoscopy, but the detection and diagnosis of dysplasia remain challenging. In this article, we review the risks of cancer and dysplasia in ulcerative colitis and the current prevention recommendations, and through a sample case, we demonstrate an approach that involves an active partnership between the gastroenterologist or surgeon and pathologist. We address the challenge of management of polypoid lesions and incorporate new information about degree of inflammation as an additional risk of neoplasia in these patients.

PMID:
17110299
PMCID:
PMC1829445
DOI:
10.1016/j.cgh.2006.09.010
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center